✦ LIBER ✦

4520226 Treatment of graft versus host disease using a mixture of T-lymphocyte specific monoclonal antibody: Ricin conjugates

Book ID: 123012583
Publisher: Elsevier Science
Year: 1985
Tongue: English
Weight: 59 KB
Volume: 3
Category: Article
ISSN: 0734-9750
DOI: 10.1016/0734-9750(85)90385-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Graft-versus-host-disease (GVHD) prophyl

Graft-versus-host-disease (GVHD) prophylaxis using antibody-ricin immunotoxins for ex vivo treatment of donor marrow

✍ John H. Kersey 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Murine monoclonal anti-T cell antibodies

Murine monoclonal anti-T cell antibodies for treatment of steroid-resistant acute graft-versus-host disease

✍ Remlinger, Kathleen; Martin, Paul J.; Hansen, John A.; Doney, Kris C.; Smith, An 📂 Article 📅 1984 🏛 Elsevier Science 🌐 English ⚖ 726 KB

Initial treatment of acute graft-versus-

Initial treatment of acute graft-versus-host disease with a murine monoclonal antibody directed to the human α/β T cell receptor

✍ Dietrich W. Beelen; Hans Grosse-Wilde; Ursula Ryschka; Klaus Quabeck; Herbert G. 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 English ⚖ 640 KB

ELIMINATION OF GRAFT-VERSUS-HOST DISEASE

ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)

✍ Waldmann, H.; Hale, G.; Cividalli, G.; Weshler, Z.; Manor, D.; Rachmilewitz, E.A 📂 Article 📅 1984 🏛 The Lancet 🌐 English ⚖ 565 KB

Prevention of Graft-Versus-Host disease

Prevention of Graft-Versus-Host disease in mice using a suicide gene expressed in T-lymphocytes

✍ J.L. Cohen; O. Boyer; B. Salomon; R. Onclercq; D. Klatzmann 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Anti-LFA1 monoclonal antibody (25.3) for

Anti-LFA1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III–IV acute graft-versus-host disease

✍ A. M. Stoppa; D. Maraninchi; D. Blaise; P. Viens; M. Hirn; D. Olive; J. Reiffers 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 537 KB

The in vivo efficacy of 25.3 monoclonal antibody (mAb) directed against human LFA1 molecule was assessed in ten patients with steroid-resistant grade III-IV acute graft-versus-host disease (AGVHD). These patients received non-T-cell-depleted allogeneic bone marrow transplantation for aplastic anemia